Clinical Trial Update: Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT [Phase 2]

View source ↗

Summary

A Phase II study evaluating gemcitabine and cisplatin with or without Iressa for bladder cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)
• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED